NO983641D0 - Fremgangsmåte til behandling og farmasöytisk preparat - Google Patents
Fremgangsmåte til behandling og farmasöytisk preparatInfo
- Publication number
- NO983641D0 NO983641D0 NO983641A NO983641A NO983641D0 NO 983641 D0 NO983641 D0 NO 983641D0 NO 983641 A NO983641 A NO 983641A NO 983641 A NO983641 A NO 983641A NO 983641 D0 NO983641 D0 NO 983641D0
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- pharmaceutical preparation
- pharmaceutical
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1132896P | 1996-02-08 | 1996-02-08 | |
| GBGB9608927.1A GB9608927D0 (en) | 1996-04-29 | 1996-04-29 | Method of treatment and pharmaceutical composition |
| PCT/US1997/001799 WO1997028797A1 (en) | 1996-02-08 | 1997-02-04 | Method of treatment and pharmaceutical composion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983641D0 true NO983641D0 (no) | 1998-08-07 |
| NO983641L NO983641L (no) | 1998-08-07 |
Family
ID=26309231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983641A NO983641L (no) | 1996-02-08 | 1998-08-07 | Fremgangsmåte til behandling og farmasöytisk preparat |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1014972A4 (no) |
| JP (1) | JPH11504044A (no) |
| KR (1) | KR19990082367A (no) |
| CN (1) | CN1210465A (no) |
| AU (1) | AU732671B2 (no) |
| BG (1) | BG102669A (no) |
| BR (1) | BR9707369A (no) |
| CA (1) | CA2245162A1 (no) |
| CZ (1) | CZ248798A3 (no) |
| EE (1) | EE9800234A (no) |
| IL (1) | IL125446A0 (no) |
| IS (1) | IS4805A (no) |
| NO (1) | NO983641L (no) |
| NZ (1) | NZ331160A (no) |
| PL (1) | PL328074A1 (no) |
| SK (1) | SK105698A3 (no) |
| TR (1) | TR199801511T2 (no) |
| WO (1) | WO1997028797A1 (no) |
| YU (1) | YU33298A (no) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214683B1 (en) | 1994-12-30 | 2007-05-08 | Sepracor Inc. | Compositions of descarboethoxyloratadine |
| US7211582B1 (en) | 1994-12-30 | 2007-05-01 | Sepracor Inc. | Methods for treating urticaria using descarboethoxyloratadine |
| GB9723985D0 (en) | 1997-11-14 | 1998-01-14 | Zeneca Ltd | Pharmaceutical compositions |
| IL136461A0 (en) * | 1997-12-23 | 2001-06-14 | Schering Corp | Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| US6194431B1 (en) | 1998-04-14 | 2001-02-27 | Paul D. Rubin | Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| US6384038B1 (en) | 1998-04-14 | 2002-05-07 | Sepracor Inc. | Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants |
| US6248308B1 (en) | 1998-04-14 | 2001-06-19 | Sepracor Inc. | Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma |
| US6262066B1 (en) | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| ID29137A (id) * | 1998-07-27 | 2001-08-02 | Schering Corp | Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1 |
| PE20001070A1 (es) * | 1998-09-10 | 2000-10-19 | Schering Corp | Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas |
| AU3924500A (en) * | 1999-03-29 | 2000-10-16 | Schering Corporation | Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine |
| DE10007203A1 (de) | 2000-02-17 | 2001-08-23 | Asta Medica Ag | Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis |
| AU2002227240A1 (en) * | 2000-10-30 | 2002-05-15 | Schering Corporation | Treatment and method using loratadine and montelukast |
| US20020198228A1 (en) * | 2001-04-03 | 2002-12-26 | Kaura Sita R. | Composition and method for the treatment of respiratory desease |
| WO2004087095A2 (es) * | 2003-03-31 | 2004-10-14 | Osmotica Costa Rica, Sociedad Anonima | Dispositivo osmótico que contiene zafirlukast y un antagonista h1 |
| WO2005037245A2 (en) * | 2003-10-21 | 2005-04-28 | Direct-Haler A/S | A multiple route medication for the treatment of rhinitis and asthma |
| WO2005089748A1 (en) * | 2004-03-17 | 2005-09-29 | Pfizer Limited | Combination for treating inflammatory diseases |
| CA2585122A1 (en) | 2004-10-25 | 2006-05-04 | Schering Corporation | M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders |
| TR200806298A2 (tr) * | 2008-08-22 | 2010-03-22 | Bi̇lgi̇ç Mahmut | Farmasötik formülasyon |
| AR077101A1 (es) | 2009-06-16 | 2011-08-03 | Schering Corp | Esteroides de heteroarilo (3,2-c), como agonistas de receptor glucocorticoide, composiciones y usos de los mismos |
| KR101540191B1 (ko) * | 2014-02-24 | 2015-07-28 | 성균관대학교산학협력단 | 로라타딘을 포함하는 항염증용 조성물 |
| WO2020143744A1 (en) * | 2019-01-10 | 2020-07-16 | Jiangyin Mucocare Pharmaceutical Co., Ltd. | New formulations containing leukotriene receptor antagonists |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4282233B1 (en) * | 1980-06-19 | 2000-09-05 | Schering Corp | Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines |
| CA1261835A (en) * | 1984-08-20 | 1989-09-26 | Masaaki Toda | (fused) benz(thio)amides |
| GB8607294D0 (en) * | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
| US5565473A (en) * | 1990-10-12 | 1996-10-15 | Merck Frosst Canada, Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| US5270324A (en) * | 1992-04-10 | 1993-12-14 | Merck Frosst Canada, Inc. | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
| US5472964A (en) * | 1992-12-22 | 1995-12-05 | Merck Frosst Canada, Inc. | Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
| US5595997A (en) * | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
-
1997
- 1997-02-04 JP JP9528627A patent/JPH11504044A/ja active Pending
- 1997-02-04 BR BR9707369A patent/BR9707369A/pt not_active Application Discontinuation
- 1997-02-04 CA CA002245162A patent/CA2245162A1/en not_active Abandoned
- 1997-02-04 CN CN97192149A patent/CN1210465A/zh active Pending
- 1997-02-04 TR TR1998/01511T patent/TR199801511T2/xx unknown
- 1997-02-04 IL IL12544697A patent/IL125446A0/xx unknown
- 1997-02-04 EE EE9800234A patent/EE9800234A/xx unknown
- 1997-02-04 CZ CZ982487A patent/CZ248798A3/cs unknown
- 1997-02-04 PL PL97328074A patent/PL328074A1/xx unknown
- 1997-02-04 NZ NZ331160A patent/NZ331160A/xx unknown
- 1997-02-04 AU AU22579/97A patent/AU732671B2/en not_active Ceased
- 1997-02-04 SK SK1056-98A patent/SK105698A3/sk unknown
- 1997-02-04 EP EP97905757A patent/EP1014972A4/en not_active Withdrawn
- 1997-02-04 WO PCT/US1997/001799 patent/WO1997028797A1/en not_active Application Discontinuation
- 1997-02-04 KR KR1019980706097A patent/KR19990082367A/ko not_active Application Discontinuation
-
1998
- 1998-07-22 IS IS4805A patent/IS4805A/is unknown
- 1998-08-05 BG BG102669A patent/BG102669A/bg unknown
- 1998-08-06 YU YU33298A patent/YU33298A/sr unknown
- 1998-08-07 NO NO983641A patent/NO983641L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EE9800234A (et) | 1998-12-15 |
| KR19990082367A (ko) | 1999-11-25 |
| NO983641L (no) | 1998-08-07 |
| BR9707369A (pt) | 1999-07-20 |
| IS4805A (is) | 1998-07-22 |
| BG102669A (bg) | 1999-04-30 |
| NZ331160A (en) | 2000-07-28 |
| PL328074A1 (en) | 1999-01-04 |
| AU2257997A (en) | 1997-08-28 |
| SK105698A3 (en) | 1999-05-07 |
| EP1014972A4 (en) | 2004-12-08 |
| EP1014972A1 (en) | 2000-07-05 |
| YU33298A (en) | 1999-11-22 |
| WO1997028797A1 (en) | 1997-08-14 |
| TR199801511T2 (xx) | 1998-10-21 |
| CN1210465A (zh) | 1999-03-10 |
| JPH11504044A (ja) | 1999-04-06 |
| CZ248798A3 (cs) | 1999-01-13 |
| CA2245162A1 (en) | 1997-08-14 |
| IL125446A0 (en) | 1999-03-12 |
| AU732671B2 (en) | 2001-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO983641D0 (no) | Fremgangsmåte til behandling og farmasöytisk preparat | |
| DK1079809T3 (da) | Enterisk overtrukket farmaceutisk sammensætning og fremgangsmåde til fremstilling deraf | |
| NO20000932L (no) | Farmasøytisk preparat for kombinasjon av piperidinoalkanol og dekongestant | |
| DK1041879T4 (da) | Desinfektionsmiddel og fremstillingsmetode | |
| NO20015888D0 (no) | Implanterbare gelpreparater og fremgangsmåte for fremstilling | |
| DK0890359T3 (da) | Beta-Lactam-antibiotikumholdige tabletter og fremgangsmåde til fremstilling deraf | |
| NO994613D0 (no) | Fremgangsmaate og preparat til behandling av sövn-apne | |
| NO985484L (no) | FremgangsmÕte og preparat for behandling og forhindring av hyperurikemi | |
| NO994778D0 (no) | FremgangsmÕter og sammensetninger for behandling av tarmbetennelse | |
| NO20004098L (no) | FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser | |
| NO973365D0 (no) | Fremgangsmåte for baking og tilhörende anordning | |
| DK0832565T3 (da) | Mælkeerstatningsprodukt og fremgangsmåde til fremstilling deraf | |
| NO970532D0 (no) | System og metode for blodbehandling | |
| IS4311A (is) | Setin 1H-imíðazól, aðferð til framleiðslu þeirra og notkun þeirra | |
| NO982329D0 (no) | Kreftvaksine og fremgangsmÕte for fremstilling derav | |
| NO980257D0 (no) | Forankringsinnretning, og fremgangsmåte ved forankring | |
| DK0702344T3 (da) | Etiketkontinuum og fremgangsmåde til fremstilling deraf | |
| DK91793A (da) | Fremgangsmåde til overfladebehandling, midler til udøvelse og anvendelsen heraf | |
| NO306932B1 (no) | Oljeaktig preparat og fremgangsmåte for fremstilling av dette | |
| NO973980D0 (no) | Imiadazolderivater og medisinsk preparat | |
| IS4779A (is) | Aðferð til að framleiða felódipín og aðferð til að framleiða lyfjablöndu | |
| NO932912D0 (no) | Preparat og fremgangsmaater til generering av ben | |
| NO973193D0 (no) | Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer | |
| DK0512547T3 (da) | Smertekontrollerende præparat og fremgangsmåde til fremstilling deraf | |
| NO20022990L (no) | Fremgangsmåte og sammensetning for behandling av smerte |